GENITOPE CORPORATION (OTC:GTOP)
Industry: Healthcare

Listed 5 Consecutive Market Days. On List as of 01/29/2007 Through 02/05/2007

Genitope Corp., a biotechnology company, offers research and development of immunotherapies for the treatment of cancer in the United States. Immunotherapies are treatments that utilize the immune system to combat diseases. It develops a panel of monoclonal antibodies for the treatment of Non-Hodgkin s Lymphoma. The company was founded in 1996 and is based in Fremont, California. On December 31, 2014, Genitope Corp. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Current Quote*
Last: $0.002
Change: 0.000
Book: $0.100
Volume: 13,588

As Of: 09/15 16:00 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol GTOP

  • No BuyIns.Net Alerts Available for GTOP

Graphs for GTOP


3 Month Graph


6 Month Graph


1 Year Graph